Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Makmur Berkah Amanda Tbk (AMAN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Makmur Berkah Amanda TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Makmur Berkah Amanda Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Makmur Berkah Amanda Tbk trades at Rp240 (market cap 937.39B, 125.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Makmur Berkah Amanda Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 125.5K). Which is the better fit depends on your goals.

AMANLABS
Market Cap
937.39B635.95B
Volume
125.5K843K
Lot
1.26K8.43K
Turnover
30.17M137.6M
Average Price
240.41163.22
Value
30.17M137.6M
Indicative Equilibrium Price
165
Indicative Equilibrium Volume
246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMAN
View details
LABS
View details

About Makmur Berkah Amanda Tbk

PT Makmur Berkah Amanda Tbk (previously PT Sidomaju Industri Estate ("Company")) was established based on Deed No.224, dated May 31, 1996 made by Erly Soehandjojo, SH, notary in Jakarta and Notary Deed Number 5 dated July 2, 1997 made Soeharto, SH, notary in Sidoarjo (here in after referred to as " The Deed of Establishment Deed"). The Company has began its commercial operations since May 31, 1996.

Read more on AMAN

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS